Mayes PA - Search Results

1

Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway.

Allen JE, Krigsfeld G, Patel L, Mayes PA, Dicker DT, Wu GS, El-Deiry WS. Allen JE, et al. Among authors: mayes pa. Mol Cancer. 2015 May 1;14:99. doi: 10.1186/s12943-015-0346-9. Mol Cancer. 2015. PMID: 25927855 Free PMC article.

2

Modulation of TRAIL-induced tumor cell apoptosis in a hypoxic environment.

Mayes PA, Campbell L, Ricci MS, Plastaras JP, Dicker DT, El-Deiry WS. Mayes PA, et al. Cancer Biol Ther. 2005 Oct;4(10):1068-74. doi: 10.4161/cbt.4.10.2255. Epub 2005 Oct 18. Cancer Biol Ther. 2005. PMID: 16294025

3

What are caspases 3 and 7 doing upstream of the mitochondria?

Kuribayashi K, Mayes PA, El-Deiry WS. Kuribayashi K, et al. Among authors: mayes pa. Cancer Biol Ther. 2006 Jul;5(7):763-5. doi: 10.4161/cbt.5.7.3228. Epub 2006 Jul 26. Cancer Biol Ther. 2006. PMID: 16921264 Review.

4

The complementary roles of the extrinsic and intrinsic apoptotic pathways in promoting the death of cancer cells.

Mayes PA, El-Deiry WS. Mayes PA, et al. Cancer J. 2006 Jul-Aug;12(4):247-9. doi: 10.1097/00130404-200607000-00001. Cancer J. 2006. PMID: 16925967 No abstract available.

5

Noninvasive vascular imaging in fluorescent tumors using multispectral unmixing.

Mayes P, Dicker D, Liu Y, El-Deiry W. Mayes P, et al. Biotechniques. 2008 Oct;45(4):459-60, 461-4. doi: 10.2144/000112946. Biotechniques. 2008. PMID: 18855773 Free article.

6

TNFSF10 (TRAIL), a p53 target gene that mediates p53-dependent cell death.

Kuribayashi K, Krigsfeld G, Wang W, Xu J, Mayes PA, Dicker DT, Wu GS, El-Deiry WS. Kuribayashi K, et al. Among authors: mayes pa. Cancer Biol Ther. 2008 Dec;7(12):2034-8. doi: 10.4161/cbt.7.12.7460. Cancer Biol Ther. 2008. PMID: 19106633

7

FLT-PET may not be a reliable indicator of therapeutic response in p53-null malignancy.

Katz SI, Zhou L, Ferrara TA, Wang W, Mayes PA, Smith CD, El-Deiry WS. Katz SI, et al. Among authors: mayes pa. Int J Oncol. 2011 Jul;39(1):91-100. doi: 10.3892/ijo.2011.1019. Epub 2011 Apr 29. Int J Oncol. 2011. PMID: 21537838

8

Overcoming hypoxia-induced apoptotic resistance through combinatorial inhibition of GSK-3β and CDK1.

Mayes PA, Dolloff NG, Daniel CJ, Liu JJ, Hart LS, Kuribayashi K, Allen JE, Jee DI, Dorsey JF, Liu YY, Dicker DT, Brown JM, Furth EE, Klein PS, Sears RC, El-Deiry WS. Mayes PA, et al. Cancer Res. 2011 Aug 1;71(15):5265-75. doi: 10.1158/0008-5472.CAN-11-1383. Epub 2011 Jun 6. Cancer Res. 2011. PMID: 21646472 Free PMC article.

9

Off-target lapatinib activity sensitizes colon cancer cells through TRAIL death receptor up-regulation.

Dolloff NG, Mayes PA, Hart LS, Dicker DT, Humphreys R, El-Deiry WS. Dolloff NG, et al. Among authors: mayes pa. Sci Transl Med. 2011 Jun 8;3(86):86ra50. doi: 10.1126/scitranslmed.3001384. Sci Transl Med. 2011. PMID: 21653830 Free PMC article.

10

Mitogen-activated protein kinase (MEK/ERK) inhibition sensitizes cancer cells to centromere-associated protein E inhibition.

Mayes PA, Degenhardt YY, Wood A, Toporovskya Y, Diskin SJ, Haglund E, Moy C, Wooster R, Maris JM. Mayes PA, et al. Int J Cancer. 2013 Feb 1;132(3):E149-57. doi: 10.1002/ijc.27781. Epub 2012 Sep 28. Int J Cancer. 2013. PMID: 22948716 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

110 results

Search Page